Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Xbiotech Inc (XBIT)

Xbiotech Inc (XBIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
XBiotech: Q3 Earnings Snapshot AP - Wed Nov 13, 2:19PM CST

XBiotech: Q3 Earnings Snapshot

XBIT : 6.38 (+0.63%)
Junior Biotech Utilizes AI To Shorten Drug Discovery Timelines, Ultimately Saving Lives Yolowire - Tue Sep 10, 5:39PM CDT

The urgent need for innovative technologies to accelerate the development of life-saving %Cancer therapies has never been more critical. With millions of lives and billions of dollars at stake, the potential...

MRK : 98.05 (-1.48%)
NVS : 97.11 (+0.35%)
KTRA : 7.5390 (-6.31%)
RKV.VN : 0.160 (+6.67%)
RHHBY : 34.5000 (+0.76%)
XBIT : 6.38 (+0.63%)
BMRN : 65.66 (+1.02%)
AZN : 65.35 (+1.41%)
XBiotech: Q2 Earnings Snapshot AP - Mon Aug 12, 1:45PM CDT

XBiotech: Q2 Earnings Snapshot

XBIT : 6.38 (+0.63%)
XBiotech: Q1 Earnings Snapshot AP - Fri May 10, 12:05PM CDT

XBiotech: Q1 Earnings Snapshot

XBIT : 6.38 (+0.63%)
XBiotech Announces Successful Completion of Phase I portion of Pancreatic Cancer Study Globe Newswire - Mon Jun 20, 2022

Novel Natrunix Treatment Shows Promise in Combination Chemotherapy for Treatment of Pancreatic Cancer...

XBIT : 6.38 (+0.63%)
XBiotech Inks Clinical Manufacturing Deal Globe Newswire - Wed Feb 2, 2022

XBiotech Manufacturing Antibody Drug for Janssen Research & Development, LLC (Janssen), One of the Janssen Pharmaceutical Companies of Johnson & Johnson...

XBIT : 6.38 (+0.63%)
XBiotech Announces First Patient Enrolled in Phase I Clinical Trial for Novel Arthritis Therapy Natrunix-SQ Globe Newswire - Wed Jan 26, 2022

Natrunix-SQ, A True Human Antibody Therapy Discovered and Manufactured at XBiotech, Is Aimed as a Breakthrough Treatment for Arthritic Disease...

XBIT : 6.38 (+0.63%)
XBiotech to Launch Novel Candidate Therapy for Stroke Globe Newswire - Thu Oct 28, 2021

Company Commencing Phase I/II Study to Test Safety and Efficacy of its New Drug Candidate to Reduce Brain Injury After Stroke...

XBIT : 6.38 (+0.63%)
Dr. Benjamin Musher to Chair Phase 1-2 Study Evaluating XBiotech’s Natrunix™ Anti-Cancer Therapy in Pancreatic Cancer Globe NewsWire - Wed Sep 8, 2021

AUSTIN, Texas, Sept. 08, 2021 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) (“XBiotech”) today announced that Benjamin Musher M.D., will chair XBiotech’s clinical program for pancreatic cancer....

XBIT : 6.38 (+0.63%)
XBiotech Announces Addition of Dr. Mark Ziats, M.D. Ph.D. as Medical Director Globe NewsWire - Mon Aug 30, 2021

Dr. Ziats Joins Clinical Team Involved in Launch and Management of Clinical Studies Across Multiple Indications

XBIT : 6.38 (+0.63%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot